GlassScriptPhysician profile
Katie Kerlin
NPI 1366859373
$8,366.81
in general payments reported to CMS, 2019-2025
9 companies · $1,293 in 2025
The $1,293 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $841 · 2022: $102 · 2023: $779 · 2024: $5,352 · 2025: $1,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,250 · Food and Beverage: $3,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,250.00 |
| Food and Beverage | $3,173.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $6,520.30 | 2021-2025 | Impella |
| Recor Medical INC | $768.47 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Abbott Laboratories | $640.92 | 2021-2024 | Mitraclip, Cardiomems, Amplatzer Amulet |
| E.R. Squibb & Sons, L.L.C. | $130.50 | 2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.00 | 2022 | |
| Amgen INC. | $91.31 | 2023 | Repatha |
| Shockwave Medical, INC | $45.48 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $33.94 | 2021 | |
| Stryker Corporation | $33.89 | 2025 | Clottriever Bold Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Kerlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.